9 / 38
Docetaxel trials (with ADT) in high-risk localized prostate cancer:
RFS
Ahlgren et al. ASCO 2016; Lin et al AUA 2016, Kellokumpu-Lethinen et al. ASCO 2018; Fizazi K. ESMO 2018
|
|
9 / 38
9 / 38
Docetaxel trials (with ADT) in high-risk localized prostate cancer:
RFS
Ahlgren et al. ASCO 2016; Lin et al AUA 2016, Kellokumpu-Lethinen et al. ASCO 2018; Fizazi K. ESMO 2018